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Advertising attempts to sell products by encouraging people to buy them. Medicine advertising similarly 
aims to persuade individuals to search or 
ask for a medicine.1 Direct-to-consumer 
advertising of prescription medicines (DTCA), 
a controversial type of advertising, has grown 
swiftly over the past few decades.2-4 DTCA 
has only been legally developed in New 
Zealand and the United States.5,6 These two 
countries have different economies and 
health systems. New Zealand has mostly 
public healthcare and self-regulated DTCA.7 
In New Zealand, advertisements are not 
independently evaluated for the quality 
and validity of scientific statements unless 
someone complains,8 and this system has 
not prevented misleading advertisements.9 
Even in the United States, which has mostly 
privately-funded healthcare7 and DTCA 
is regulated and overseen by the Food 
and Drug Administration, violations by 
pharmaceutical companies are prevalent, 
predominantly for providing misleading 
information.10-13
DTCA both benefits and harms public 
health.14-16 Given that some medications are 
underused and some are overused, DTCA 
that increases prescribing may have positive 
or negative effects.16 DTCA can have positive 
outcomes when the disease to be treated is 
severe and the medicine is safe, effective and 
underused; whereas, when the condition is 
not serious and the medicine is potentially 
unsafe, less effective or overused, the effects 
of DTCA will be negative.16 Supporters 
argue that DTCA can inform and empower 
the public and increase their autonomy by 
educating them about medical conditions 
and possible treatments.17-19 However, even 
though DTCA may inform individuals, it may 
also mislead them.14 Critics argue that DTCA 
is persuasive rather than informative because 
it presents partial and biased information 
that exaggerates the potential benefits 
of medicines.17,20-23 DTCA has also been 
criticised for using ‘scare-mongering’ tactics to 
encourage patients to start a treatment.24,25
Past research shows DTCA leads to the 
advertised medicines being sought and 
requested by individuals.12,17,26,27 Of note, 
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Abstract 
Objective: Direct-to-consumer advertising of prescription medicines encourages individuals 
to search for or request advertised medicines, can stimulate taking medications rather than 
making lifestyle behaviour changes, and may target individuals with poorer demographic and 
socioeconomic status and riskier health-related behaviours. This study thus explored whether 
responses to medicine advertising vary as a function of lifestyle behaviours, and demographic 
and socioeconomic factors.
Methods: Data were collected through an online survey of a nationally representative sample 
of 2,057 adults in New Zealand. Multivariate binary logistic regressions were used to explore 
whether lifestyle behaviours, including nutritional habits, alcohol consumption, illegal drug 
consumption, physical activity, attitudes towards doing exercise, as well as demographic and 
socioeconomic status were associated with self-reported behavioural responses to medicine 
advertising.
Results: Individuals who had unhealthier lifestyle behaviours were more likely to respond to 
medicine advertising.
Conclusions: The findings raise concerns regarding the misuse or overuse of medications for 
diseases that may otherwise be improved by a healthier lifestyle.
Implications for public health: To improve public health and wellbeing of society, we call for 
regulatory changes regarding advertising of medicines. Where applicable, lifestyle changes 
should be advertised as potential substitutes for the advertised medicines. Interprofessional 
collaboration is also recommended to educate individuals and convey the value of health 
behaviour changes.
Key words: direct-to-consumer advertising, prescription medicines, self-reported behavioural 
outcomes, lifestyle behaviours, New Zealand
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studies reveal that when a message shows 
a medicine as very effective, individuals do 
not try to process the rest of the information 
presented in the message.28 Doctors may 
face extra work and frustration if a patient 
discusses the medicine with them as a result 
of ‘evidence’ from an advertisement.14,28 
Research also shows that when patients 
request a specific medicine; doctors usually 
prescribe it.21,29,30 Further, advertising a 
medication as the solution to a health 
condition may cause audiences to think that 
healthy lifestyles, such as proper nutrition and 
exercise, are ineffective or needless.31 Hence, 
the influence of medicine advertising on 
consumers with unhealthier lifestyle practices 
is of particular concern.
Research discusses that DTCA can change 
people’s views on normal and medical 
conditions by encouraging the use of 
medicine to cure ‘every ill’.32,33 Aspects of 
bodily experiences, which are normally 
reflections of individuals’ lifestyles, have 
been medicalised by the pharmaceutical 
industry’s efforts to find treatments for 
these ‘new’ illnesses.34,35 Lifestyle behaviours 
can affect both consumer behaviour36 and 
consumer health.37-42 Lifestyle has been 
studied as a leading contributor to health 
outcomes by researchers.43 Previous research 
has established that the study of lifestyle 
behaviours can provide more information 
about, and a better picture of, individuals 
than their demographics.36 Lifestyle 
comprises people’s daily behaviours, such as 
activities, fun and nutrition.43 Health lifestyles 
are defined as health-related behaviours 
according to individuals’ preferences from 
available options.44 Unhealthy nutrition, 
physical inactivity, drug abuse, smoking, 
alcohol consumption and medicine abuse 
are common indicators of an unhealthy 
lifestyle.41-43,45 According to existing studies, 
engaging in one or more unhealthy lifestyle 
behaviours advances the risk of death.46-49 A 
meta-analysis revealed that having a healthy 
lifestyle is linked to a lower risk of death so 
that a mix of healthy lifestyle behaviours, such 
as not smoking, moderate alcohol drinking, 
healthy nutrition, regular physical activity, 
and having an optimal weight, was linked to a 
66% decrease in mortality.48
Furthermore, “demographic and 
socioeconomic factors are major 
determinants of health”.50(p131) The social 
determinants of health, “the conditions in 
which people are born, grow, live, work and 
age”,(p36) can result in health inequalities.51 
Research demonstrates that people with 
lower socioeconomic status have poorer 
health conditions.51 “Health behaviour is 
greatly influenced by peoples’ environmental, 
socioeconomic and cultural settings”.52(p213) 
Earlier studies show that being socially or 
economically disadvantaged (e.g. having low 
income) is associated with unhealthy lifestyle 
factors, such as physical inactivity, smoking 
and being obese.51-54 Moreover, disparities 
in health information seeking have been 
associated with gender, education, age and 
ethnicity.27,55-58 For instance, women and 
individuals who had lower income and were 
less educated, older, and ethnic minorities 
were more likely to respond to DTCA.27 
In summary, individuals with less 
healthy lifestyle behaviours and poorer 
socioeconomic characteristics are more likely 
to have health issues,46,47,59 and thus may be 
at higher risk of being medicalised. Given 
their poorer health and the fact that DTCA 
can be misleading and emotive,60 and focus 
on taking medications rather than changing 
lifestyle behaviours,61 such individuals might 
be more at risk of responding to DTCA. 
The present study thus extends previous 
research, which found that demographic 
and socioeconomic factors associated 
with responding to DTCA,27 to examine 
whether lifestyle factors also help to explain 
individuals’ responses to DTCA. Specifically, 
this study examines whether individuals 
who have unhealthier lifestyles are more 
likely to report being influenced by medicine 
advertising. 
Methods
Study sample
This exploratory study analysed data 
collected by an Australasian market research 
company through an online survey of 2,057 
adults in New Zealand in 2013. A quota 
sampling method was used, capturing a 
nationally-representative sample of the 
New Zealand population, to allow for 
generalisability of the results. The survey had 
ethical approval from the University of Otago, 
and all participants gave their informed 
consent.
Variables and measures 
The data used in this study came from a larger 
research project on consumer behaviour and 
lifestyle. In this study, measures and variables 
relevant to demographics, socioeconomics, 
lifestyle factors and behavioural responses to 
DTCA were explored.
Dependent variables
Self-reported behaviours in response to 
seeing an advertisement for a medicine27 
were measured by four yes/no questions 
adapted from prior studies: ‘As a result of 
seeing an advertisement for a drug, have 
you asked your doctor for a prescription?’;62 
‘As a result of seeing an advertisement for a 
drug, have you asked your doctor for more 
information about an illness?’;62 ‘As a result of 
seeing an advertisement for a drug, have you 
searched the Internet for more information 
regarding an illness?’;1,63 and ‘As a result of 
seeing an advertisement for a drug, have you 
asked your pharmacist for more information 
about a drug?’.62
Independent variables 
Common indicators of a healthy/unhealthy 
lifestyle, i.e. nutritional habits, substance 
abuse (including consumption of illicit drugs 
and alcohol), physical activity,41,42,45 as well 
as attitude towards doing exercise were 
independent variables. 
Nutritional habits were evaluated using 
a summed index of twelve yes (1)/no (2) 
statements pertaining to the consumption 
of different food categories in the past 24 
hours; higher values indicate more healthy 
nutritional habits. Healthy food habits 
included eating: vegetables, fruit, breakfast, a 
meal at home that was made from scratch (i.e. 
no pre-prepared packets were used). Healthy 
food habits were subsequently reverse 
scored. Unhealthy food habits included 
eating: confectionery (e.g. lollies, sweets), 
potato chips and/or chocolate; fast food (e.g. 
McDonalds, fish and chips); takeaways (e.g. 
Thai, Indian); at a restaurant or café; a meal at 
home made from pre-prepared food/sauces 
(e.g. frozen chips, pre-prepared rice risotto 
from a packet, pasta sauce); biscuits, cakes, or 
pastries; dessert or ice cream; and drinking 
fizzy drink containing sugar (e.g. Coke, Sprite; 
adapted from Food Standards Agency64).
Illegal drug consumption was assessed by 
a summed index of two statements, made 
on a five-point scale: 0 (never), 1 (rarely), 
2 (occasionally), 3 (often) to 4 (daily), 
regarding consumption of marijuana and 
consumption of speed, ecstasy or magic 
mushrooms (modified from past research)65 
in the past 12 months. Higher values indicate 
more consumption. For measuring alcohol 
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consumption, participants were asked to 
indicate the type and volume of standard 
drinks consumed on their heaviest drinking 
occasion in the past seven days.66-68 This 
measure has been noted to represent ‘at 
risk’ drinking68 and the period of seven 
days provides a thorough picture of alcohol 
consumption69 and moderates the chances 
of under-reporting, even though it does 
not consider the occasional drinking of 
participants.70 Before the estimation of 
alcohol consumption, the alcohol percentage 
by volume (ABV) was reviewed and 
revised for each record.66 Standard drink 
consumption was measured by applying the 
equation indicated by the Food Standards 
Authority Australia and New Zealand (FSANZ) 
and used in an earlier study: “volume of the 
container in liters × % alcohol by volume 
(ml/100 ml) × 0.789”.66,71
Physical activity was determined through 
a summed index of four statements (0: 
not selected / 1: going to/participating in) 
measuring engagement in physical activities 
in an average month, including going to the 
gym/run/walk, participating in individual 
sport (e.g. swimming, golf ), participating in a 
team sport, and going tramping or camping. 
Higher values indicate more physical 
activities. Consumers’ attitude towards doing 
exercise was measured by a single item 
measuring attitude towards the importance 
of doing exercise, made on a five-point Likert 
scale from 1 (strongly disagree) to 5 (strongly 
agree). All questions came from the New 
Zealand lifestyle survey, which is a part of an 
ongoing project performed by the University 
of Otago since 1979.
Demographic and socioeconomic variables 
were also considered in the models: gender, 
age (as a continuous variable), ethnicity (as 
multiple dummy variables, with New Zealand 
European as the reference level), income, and 
level of education (as ordered categorical 
variables).27 
Statistical analysis
Data were analysed using IBM SPSS 
Statistics, Version 22.0. Descriptive statistics 
were employed to calculate frequencies, 
in addition to the mean, and standard 
deviation of items. Multivariate binary logistic 
regression models were used to reveal the 
factors determining self-reported behavioural 
outcomes. For each model, odds ratios 
(ORs) with 95% confidence intervals (CIs) 
were examined. Accuracy of prediction and 
overall appropriateness of the models were 
examined by significant (p<0.01) Omnibus 
test of model coefficients, and nonsignificant 
(p>0.05) Hosmer–Lemeshow tests.72
Results
Descriptive statistics
The demographics and socioeconomics of 
the sample are shown in Table 1.27 Table 2 
shows the means and standard deviations for 
non-demographic independent variables.
Predictors of behavioural outcomes
Results of the multivariate binary logistic 
regression models predicting self- reported 
behavioural responses to DTCA are presented 
in Table 3. 
Asking a doctor for a prescription
Asking a doctor for a prescription was 
associated with older age (OR=1.01, 95%CI 
1.001-1.02), higher alcohol consumption 
(OR=1.03, 95%CI 1.01-1.05), more illegal drug 
consumption (OR=1.29, 95%CI 1.17-1.42); 
lower education (OR=0.90, 95%CI 0.83-
0.97), less positive attitudes toward doing 
exercise (OR=0.79, 95%CI 0.66-0.94), doing 
less exercise (OR=0.78, 95%CI 0.69-0.89), 
and less healthy eating habits (OR=0.84, 
95%CI 0.78-0.91). Chinese (OR=2.24, 95%CI 
1.11-4.51), and Indian (OR=6.05, 95%CI 
3.37-10.86) respondents were more likely 
to ask a doctor for a prescription than New 
Zealand Europeans. Gender and income did 
not have any influence on asking a doctor for 
a prescription. This model correctly classified 
the outcome for 88.6% of the cases and 
demonstrated a good fit to the data (Table 3).
Asking a doctor for more information 
about an illness
Asking a doctor about an illness was 
associated with more illegal drug 
consumption (OR=1.11, 95%CI 1.01-1.23), 
older age (OR=1.02, 95%CI 1.01-1.03), lower 
income (OR=0.89, 95%CI 0.83-0.96), doing 
less exercise (OR=0.78, 95%CI 0.70-0.88), and 
less healthy eating habits (OR=0.88, 95%CI 
0.82-0.94). Maori (OR=2.06, 95%CI 1.42-2.99), 
Chinese (OR=2.05, 95%CI 1.07-3.91), Indian 
(OR=4.14, 95%CI 2.40-7.12), and ‘Other’ 
ethnicities (OR=1.52, 95%CI 1.06-2.16) were 
more likely than New Zealand Europeans 
to ask a doctor for more information about 
an illness. Alcohol consumption, attitudes 
toward doing exercise, education and gender 
did not have any influence on asking a 
doctor about an illness. This model correctly 
classified the outcome for 84.1% of the cases 
and showed a good model fit (Table 3).
Searching the Internet for more 
information regarding an illness
Seeking more information from the Internet 
regarding an illness was associated with 
more positive attitudes toward doing 
exercise (OR=1.15, 95%CI 1.02-1.30), doing 
less exercise (OR=0.84, 95%CI 0.77-0.92), 
and less healthy eating habits (OR=0.93, 
95%CI 0.89-0.98). Indian (OR=1.71, 95%CI 
1.06-2.77), and ‘Other’ ethnicities (OR=1.31, 
95%CI 1.01-1.70) were more likely than New 
Table 1: Demographics and socioeconomics of the 
Sample (n=2,057) .
Variable Frequency 
(%)
Mean S.D.
Age (years)  
(Continuous variable)
44.21 17.60
Education n(%)  
 No secondary schooling 61 (3.0)
 School examinations only 165 (8.0)
 School certificate 
examination only
355 (17.3)
 University entrance/ 
Matriculation only
277 (13.5)
 Technical or trade 
certificates
329 (16.0)
 Professional training 215 (10.5)
 University qualifications 655 (31.8)
Ethnicity n(%)  
 New Zealand European 1,290 (62.7)
 Maori 218 (10.6)
 Chinese 74 (3.6)
 Indian 79 (3.8)
 Pacific Islands 68 (3.3)
 ‘Other’ Ethnicities 328 (15.9)
Gender n(%)  
 Male 1,001 (48.7)
 Female 1,056 (51.3)
Income (annual) n(%)
 Less than $NZ20,000 199 (9.7)
 $NZ20,000–$NZ39,999 460 (22.4)
 $NZ40,000–$NZ59,999 413 (20.1)
 $NZ60,000–$NZ79,999 338 (16.4)
 $NZ80,000–$NZ99,999 212 (10.3)
 $NZ100,000–$NZ119,999 202 (9.8)
 Over $NZ120,000 232 (11.3)
Table 2: Non-demographic independent variables.
Items Scale 
Range
Mean (SD)
Alcohol consumption 0-61.3 3.16 (5.90)
Attitudes towards doing exercise 1-5 4.26 (0.80)
Healthy eating habits 12-24 22.06 (2.07)
Illegal drug consumption 0-8 0.46 (1.19)
Physical activity 0-4 2.56 (1.10)
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consumption predicted all self-reported 
behavioural responses except for searching 
the Internet for more information regarding 
an illness. Higher alcohol consumption and 
less positive attitudes toward doing exercise 
predicted asking a doctor for a prescription. 
However, more positive attitudes toward 
doing exercise predicted searching the 
Internet for more information, which could 
be owing to a mediating factor that can be 
explored in future research. 
Studies on health inequalities have 
attempted to reveal the behavioural factors 
that are associated with health outcomes, 
particularly lifestyle behaviours (e.g. physical 
inactivity, drug or alcohol consumption, 
unhealthy nutrition).76 Earlier research has 
indicated that personal lifestyle causes 
health disparities;43,77,78 individuals’ risk of 
poor health advances when they undertake 
unhealthy lifestyle behaviours.46,47,59 
An alternative explanation is that these 
unhealthy lifestyle behaviours and health 
inequalities may be caused by socioeconomic 
and cultural disparities.52,79-81
This is, however, the first study to reveal the 
association between lifestyle factors and 
behavioural responses to DTCA. The present 
findings extend existing research by showing 
that individuals who have a tendency towards 
poorer lifestyle choices, are more receptive 
to medicine advertising than those with 
healthier lifestyles. This association could 
be due to individuals with poorer lifestyle 
behaviours being more likely to have poorer 
health,74,75 and/or their desire to take a 
medicine rather than changing lifestyle 
behaviours.
The finding that individuals with less healthy 
lifestyles are more likely to be influenced 
by DTCA is of significant concern given 
that DTCA does not usually focus on public 
health issues such as nutrition, exercise, 
addictions and appropriate consumption 
of current medications.16 Thus, DTCA can 
result in public pharmaceuticalisation, which 
leads to the use of lifestyle medicines (e.g. 
weight loss pills), perceived by individuals 
“as a ‘magic bullet’ to resolve problems of 
daily life”.82(p856) Accordingly, DTCA may 
stimulate taking medicines rather than 
making lifestyle behavioural changes and 
may be more appealing to individuals with 
less healthy lifestyles, as evidenced in the 
current study. DTCA can even result in doctors 
being pressured to prescribe a medication 
in instances where lifestyle changes would 
be more appropriate. Although DTCA is 
Table 3: Multivariate binary logistic regression models predicting self-reported behavioural responses to DTCA
Variable Asking a doctor for 
a prescription:a 
OR (95% CI)
Asking a doctor 
for more 
information 
about an illness:b 
OR (95% CI)
Searching the 
Internet for more 
information 
regarding an illness:c 
OR (95% CI)
Asking a 
pharmacist for 
more information 
about a drug:d 
OR (95% CI)
Age 1.01 (1.001-1.02)*  1.02 (1.01-1.03)***  1.003 (0.997-1.01)  1.02 (1.01-1.03)***
Alcohol consumption  1.03 (1.01-1.05)** 1.005 (0.98-1.02)  1.01 (0.99-1.03)  0.99 (0.97-1.01)
Attitudes towards doing exercise  0.79 (0.66-0.94)** 0.99 (0.85-1.16) 1.15 (1.02-1.30)*  1.07 (0.91-1.26)
Ethnicity 
 New Zealand  European (Reference) 1.00 1.00 1.00 1.00
 Maori 1.53 (0.98-2.40) 2.06 (1.42- 2.99)***  1.20 (0.89-1.64)  2.32 (1.61-3.34)***
 Chinese  2.24 (1.11-4.51)*  2.05 (1.07-3.91)* 1.32 (0.79-2.19)  2.55 (1.40-4.61)**
 Indian  6.05 (3.37-10.86)*** 4.14 (2.40-7.12)***  1.71 (1.06-2.77)*  1.93 (1.06-3.53)*
 Pacific Islands  1.18 (0.52-2.69) 1.70 (0.87-3.33)  1.33 (0.79-2.22)  2.11 (1.12-3.98)*
 ‘Other’ Ethnicities 1.47 (0.95-2.25) 1.52 (1.06-2.16)*  1.31 (1.01-1.70)* 1.98 (1.42-2.76)***
Gender 0.89 (0.65-1.21) 0.93 (0.72-1.22) 1.48 (1.21-1.82)***  1.17 (0.90-1.52)
Illegal drug consumption 1.29 (1.17-1.42)***  1.11 (1.01-1.23)*  1.02 (0.94-1.10)  1.22 (1.11-1.34)***
Level of annual income 0.92 (0.85-1.005) 0.89 (0.83-0.96)* 0.98-(0.93-1.04) 0.95 (0.88-1.01)
Level of Education 0.90 (0.83-0.97)*  0.96 (0.90-1.04) 0.997 (0.94-1.05)  1.02 (0.95-1.10)
Nutritional habits 0.84 (0.78-0.91)*** 0.88 (0.82-0.94)***  0.93 (0.89-0.98)** 0.91 (0.86-0.97)**
Physical activity  0.78 (0.69-0.89)*** 0.78 (0.70-0.88)*** 0.84(0.77-0.92)*** 0.87 (0.77-0.97)*
Notes:
*p < 0.05  **p < 0.01  ***p < 0.001
a. R2=0.14 (Nagelkerke), 0.07 (Cox-Snell); Hosmer–Lemeshow test (χ² = 11.83, d.f. = 8, p = 0.16); Omnibus Tests of Model Coefficients (p < 0.001)
b. R2=0.08 (Nagelkerke), 0.05 (Cox-Snell); Hosmer–Lemeshow test (χ² = 6.71, d.f. = 8, p = 0.57); Omnibus Tests of Model Coefficients (p < 0.001)
c. R2=0.04% (Nagelkerke), 0.03 (Cox-Snell); Hosmer–Lemeshow test (χ² = 5.37, d.f. = 8, p = 0.72); Omnibus Tests of Model Coefficients (p < 0.001)
d. R2=0.07 (Nagelkerke), 0.04 (Cox-Snell); Hosmer–Lemeshow test (χ² = 10.98, d.f. = 8, p = 0.20); Omnibus Tests of Model Coefficients (p < 0.001) 
Zealand Europeans to search the Internet 
for more information. Moreover, women 
were more likely to search the Internet for 
more information than men (OR=1.48, 95%CI 
1.21-1.82). Illegal drug consumption, alcohol 
consumption, education, age and income 
did not have any influence on searching the 
Internet for more information. This model 
correctly classified the outcome for 65.7% of 
the cases and demonstrated a good fit to the 
data (Table 3).
Asking a pharmacist for more 
information about a drug
Asking a pharmacist for more information 
about an advertised drug was associated with 
older age (OR=1.02, 95%CI 1.01-1.03), more 
illegal drug consumption (OR=1.22, 95%CI 
1.11-1.34), doing less exercise (OR=0.87, 
95%CI 0.77- 0.97), and less healthy eating 
habits (OR=0.91, 95%CI 0.86-0.97). All ethnic 
minorities, including Maori (OR=2.32, 95%CI 
1.61-3.34), Chinese (OR=2.55, 95%CI 1.40-
4.61), Indian (OR=1.93, 95%CI 1.06-3.53), 
Pacific Islands (OR=2.11, 95%CI 1.12-3.98) and 
Other ethnicities (OR=1.98, 95%CI 1.42-2.76), 
were more likely to ask a pharmacist for more 
information about a drug than New Zealand 
Europeans. Alcohol consumption, attitudes 
toward doing exercise, education, gender and 
income did not have any influence on asking 
a pharmacist for more information. This 
model precisely classified the outcome for 
83.9% of the cases and showed a good model 
fit (Table 3). 
Discussion
DTCA has been criticised for altering 
individuals’ perceptions of health and illness, 
including encouraging the medicalisation of 
normal conditions and pharmaceuticalisation 
over healthy lifestyle choices;16,73 while 
unhealthier lifestyle behaviours have been 
linked to a higher possibility of poorer 
health.74,75 Previous research revealed that 
women and individuals who had lower 
income and were less educated, older, and 
ethnic minorities were more likely to report 
behavioural responses to DTCA.27 The current 
study extended earlier research by examining 
the links between individuals’ healthy/
unhealthy lifestyle practices, in addition 
to already established demographic and 
socioeconomic factors, and their self-reported 
behavioural responses to DTCA. The findings 
of the current exploratory study revealed that 
individuals with unhealthier lifestyles were 
more likely to be influenced by DTCA. 
Physical inactivity and unhealthy eating 
behaviours predicted all self-reported 
behavioural responses to DTCA. Illegal drug 
Zadeh, Robertson and Green
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presented by pharmaceutical companies 
as a type of information that is ‘in the best 
interests of individuals’,17 research has shown 
that the main goal of medicine advertising 
is to persuade rather than to inform, and it 
has been successful at persuasion.21,22 Thus, 
the public needs to be informed that DTCA 
is a marketing tool, predominantly aimed 
at affecting prescribing behaviour, driving 
choice, and increasing profit.83-85
Limitations 
The current findings were based on a cross-
sectional survey; thus, causal conclusions 
cannot be made. Moreover, the respondents’ 
self-reported lifestyle behaviours, as well 
as self-reported behavioural responses to 
DTCA, might not reflect individuals’ actual 
behaviours and might increase the possibility 
that certain behaviours were under or over 
reported. However, the anonymity assured by 
the online survey platform, a method that has 
strengths over traditional methods,86 would 
have assisted truthful responses.71 
This study was exploratory research and 
included a large pool of potential predictors, 
which should be useful in guiding future, 
more confirmatory work. However, this issue 
can increase the chance of observing a Type I 
error. Moreover, since the data did not include 
tobacco use behaviours, future research could 
extend the current findings by exploring 
the relationship between smoking as an 
unhealthy lifestyle factor, and behavioural 
responses to medicine advertising. 
Conclusions
While much attention has been paid to 
the effects of lifestyles on individuals’ 
behaviour (e.g. buying behaviour),36 and 
health inequalities,37-42,45 to the best of our 
knowledge, no study has documented 
DTCA-triggered behavioural responses of 
individuals with less healthy lifestyle habits. 
This study primarily revealed that individuals 
with unhealthier lifestyles, that is, less physical 
activity, higher levels of alcohol consumption, 
unhealthier nutritional habits and higher 
levels of illegal drug use, were more likely 
to respond to DTCA. The negative attitude 
towards doing exercise also influenced asking 
a doctor for a prescription. Overall, these 
associations, along with previously reported 
findings27 linking being a woman, increasing 
age, lower income, lower education and 
belonging to an ethnic minority suggest that 
these ‘at risk’ or ‘disadvantaged’ groups can 
be more susceptible towards DTCA and may 
not be able to make informed decisions. This 
raises concerns regarding the ethicality of 
DTCA in its current form, especially given that 
DTCA is self-regulated in New Zealand.
Implications
The findings of our large representative 
sample can be generalised to the national 
population in New Zealand and have 
important implications for both public 
health policy makers and pharmaceutical 
companies. Considering the findings of 
this study together with the outcomes of 
earlier studies regarding individuals’ positive 
attitudes towards medicine advertising,27 
awareness on lifestyle changes should be 
supported through a combination of efforts 
to facilitate healthy behaviours.87 Accordingly, 
based on our findings, we call for the 
pharmaceutical industry to stress healthy 
lifestyle behaviours as an alternative to taking 
medications, where applicable. Furthermore, 
pharmaceutical companies should not target 
‘at risk’ individuals, position their products 
based on individuals’ lifestyle characteristics 
and depict their product as a wonder drug. 
Instead, they need to make DTCA more 
ethical by explicitly and impartially stating 
that behavioural changes could be as 
effective as taking the advertised medicine. 
Communications on lifestyle changes in DTCA 
need to more specifically target those with 
unhealthy lifestyles. These actions can also 
benefit pharmaceutical companies since it is 
in the companies’ lasting interest to advertise 
responsively, fairly and truthfully.88 
This study also highlights the need for 
interprofessional collaborations to educate 
individuals and convey the value of health 
behaviour changes to help ‘disadvantaged’ 
groups make more informed health-related 
decisions. Healthcare professionals thus can 
become “both gatekeepers and influencers 
over the purchase of the prescription 
medicine, and make the purchase not 
only a cognitive process, but also a social 
process”.89(p275) They can play an important 
role in educating and supporting peoples’ 
health behaviour changes90 as well as 
moderating the potential negative effects 
of DTCA and its persuasion process on 
individuals’ decision making, consistent with 
consumer socialisation theory that highlights 
the influence of socialisation agents in 
consumers’ decision-making process.89,91,92
Since social and economic disparities 
can result in health behaviour and health 
inequalities,51 health promotion policy 
should also consider social determinants in 
addition to motivating individual actions for 
changing unhealthy behaviours.52 Previous 
research discussed that rules which may harm 
individuals’ health should be changed.93 In 
line with existing research,94 the findings of 
this study suggest that the current rules on 
DTCA are not sufficient to protect consumers, 
and reinforce the need for tighter control and 
regulatory actions on DTCA. This study also 
proposes that the government should focus 
on increasing individuals’ health literacy, 
monitor advertising of lifestyle medicines 
and ensure that DTCA is more beneficial than 
harmful, to help individuals make informed 
decisions. It is hoped that this controversial, 
but powerful, medium can be utilised to 
improve the wellbeing of society.
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